| Date Filed | Type | Description |
| 08/07/2023 |
4
| Rickard Kathleen A. (Chief Medical Officer) has filed a Form 4 on Verona Pharma plc|
Txns:
| Sold 28,752 shares
@ $2.55, valued at
$73.3k
Sold 21,848 shares
@ $2.539, valued at
$55.5k
Sold 27,944 shares
@ $2.4992, valued at
$69.8k
Sold 1,600 shares
@ $2.4679, valued at
$3.9k
|
|
| 08/07/2023 |
4
| ZACCARDELLI DAVID (President and CEO) has filed a Form 4 on Verona Pharma plc|
Txns:
| Sold 117,272 shares
@ $2.539, valued at
$297.8k
Sold 150,000 shares
@ $2.4992, valued at
$374.9k
Sold 8,616 shares
@ $2.4679, valued at
$21.3k
|
|
| 08/07/2023 |
4
| Hahn Mark W (CFO) has filed a Form 4 on Verona Pharma plc|
Txns:
| Sold 117,272 shares
@ $2.539, valued at
$297.8k
Sold 150,000 shares
@ $2.4992, valued at
$374.9k
Sold 8,616 shares
@ $2.4679, valued at
$21.3k
|
|
| 08/07/2023 |
4
| Poll Claire (General Counsel) has filed a Form 4 on Verona Pharma plc|
Txns:
| Sold 20,608 shares
@ $2.539, valued at
$52.3k
Sold 26,352 shares
@ $2.4992, valued at
$65.9k
Sold 1,512 shares
@ $2.4679, valued at
$3.7k
Gifted 89,976 shares
@ $0
Gifted 89,976 shares
@ $0 |
|
| 08/03/2023 |
4
| Hahn Mark W (CFO) has filed a Form 4 on Verona Pharma plc|
Txns:
| Sold 105,944 shares
@ $2.679, valued at
$283.8k
Sold 73,704 shares
@ $2.593, valued at
$191.1k
|
|
| 08/03/2023 |
4
| Poll Claire (General Counsel) has filed a Form 4 on Verona Pharma plc|
Txns:
| Sold 18,608 shares
@ $2.679, valued at
$49.9k
Sold 12,944 shares
@ $2.593, valued at
$33.6k
|
|
| 08/03/2023 |
4
| ZACCARDELLI DAVID (President and CEO) has filed a Form 4 on Verona Pharma plc|
Txns:
| Sold 105,944 shares
@ $2.679, valued at
$283.8k
Sold 73,704 shares
@ $2.593, valued at
$191.1k
|
|
| 08/03/2023 |
4
| Rickard Kathleen A. (Chief Medical Officer) has filed a Form 4 on Verona Pharma plc|
Txns:
| Sold 19,736 shares
@ $2.679, valued at
$52.9k
Sold 13,728 shares
@ $2.593, valued at
$35.6k
|
|
| 08/03/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 08/03/2023 |
10-Q
| Quarterly Report for the period ended June 30, 2023 |
| 08/03/2023 |
8-K
| Quarterly results |
| 05/16/2023 |
SC 13D/A
| ORBIMED ADVISORS LLC reports a 4.8% stake in Verona Pharma plc |
| 05/15/2023 |
4
| ORBIMED ADVISORS LLC (Director) has filed a Form 4 on Verona Pharma plc|
Txns:
| Sold 80,000 shares
@ $22.26, valued at
$1.8M
Sold 43,200 shares
@ $21.64, valued at
$934.8k
Sold 14,400 shares
@ $21.96, valued at
$316.2k
Sold 345,313 shares
@ $20, valued at
$6.9M
|
|
| 05/15/2023 |
4
| Gupta Rishi (Director) has filed a Form 4 on Verona Pharma plc|
Txns:
| Sold 80,000 shares
@ $22.26, valued at
$1.8M
Sold 43,200 shares
@ $21.64, valued at
$934.8k
Sold 14,400 shares
@ $21.96, valued at
$316.2k
Sold 345,313 shares
@ $20, valued at
$6.9M
|
|
| 05/11/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 05/11/2023 |
4/A
| Poll Claire (General Counsel) has filed a Form 4 on Verona Pharma plc|
Txns:
| Exercised 8,328 options to buy
@ $0 |
|
| 05/11/2023 |
4/A
| Rickard Kathleen A. (Chief Medical Officer) has filed a Form 4 on Verona Pharma plc|
Txns:
| Exercised 15,000 options to buy
@ $0 |
|
| 05/09/2023 |
S-8
| Form S-8 - Securities to be offered to employees in employee benefit plans: |
| 05/09/2023 |
10-Q
| Quarterly Report for the period ended March 31, 2023 |
| 05/09/2023 |
8-K
| Quarterly results |
| 05/03/2023 |
4
| Poll Claire (General Counsel) has filed a Form 4 on Verona Pharma plc|
Txns:
| Sold 80,376 shares
@ $2.5759, valued at
$207k
|
|
| 05/03/2023 |
4
| Rickard Kathleen A. (Chief Medical Officer) has filed a Form 4 on Verona Pharma plc|
Txns:
| Sold 77,424 shares
@ $2.5759, valued at
$199.4k
Sold 28,752 shares
@ $2.6517, valued at
$76.2k
|
|
| 05/03/2023 |
4
| Hahn Mark W (CFO) has filed a Form 4 on Verona Pharma plc|
Txns:
| Sold 455,528 shares
@ $2.5759, valued at
$1.2M
|
|
| 05/03/2023 |
4
| ZACCARDELLI DAVID (President and CEO) has filed a Form 4 on Verona Pharma plc|
Txns:
| Sold 455,536 shares
@ $2.5759, valued at
$1.2M
|
|
| 05/03/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 05/01/2023 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 04/28/2023 |
4
| Deschamps Lisa (Director) has filed a Form 4 on Verona Pharma plc|
Txns:
| Granted 96,000 options to buy
@ $0 |
|
| 04/28/2023 |
4
| Ullman Anders (Director) has filed a Form 4 on Verona Pharma plc|
Txns:
| Granted 96,000 options to buy
@ $0 |
|
| 04/28/2023 |
4
| SHAH MAHENDRA (Director) has filed a Form 4 on Verona Pharma plc|
Txns:
| Granted 96,000 options to buy
@ $0 |
|
| 04/28/2023 |
4
| EBSWORTH DAVID R (Director) has filed a Form 4 on Verona Pharma plc|
Txns:
| Granted 96,000 options to buy
@ $0 |
|
| 04/28/2023 |
4
| Edwards Martin (Director) has filed a Form 4 on Verona Pharma plc|
Txns:
| Granted 96,000 options to buy
@ $0 |
|
| 04/28/2023 |
4
| Gupta Rishi (Director) has filed a Form 4 on Verona Pharma plc|
Txns:
| Granted 96,000 options to buy
@ $0 |
|
| 04/28/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/28/2023 |
4
| Cunningham Kenneth (Director) has filed a Form 4 on Verona Pharma plc|
Txns:
| Granted 96,000 options to buy
@ $0 |
|
|